Findings

What do systematic reviews say?

13 questions · 13 findings · 2 reviews · Skin

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3 · 23.1%GRADE not reported 0 · 0%Very low 0 · 0%Low 6 · 46.2%Moderate 4 · 30.8%High 0 · 0%

Oral tetracycline vs topical clindamycin

Participant global assessment VAS Visual analogue scale (VAS) (0 to 100 mm) · participants with hidradenitis suppurativa

1 finding from 1 review

Interventions for hidradenitis suppurativa 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Low

Oral tetracycline vs topical clindamycin

Pain VAS VAS (0 to 100 mm) · participants with hidradenitis suppurativa

1 finding from 1 review

Interventions for hidradenitis suppurativa 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Low

Oral tetracycline vs topical clindamycin

Nodules score Nodule count · participants with hidradenitis suppurativa

1 finding from 1 review

Interventions for hidradenitis suppurativa 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Low

Oral tetracycline vs topical clindamycin

Abscesses score Abscess count · participants with hidradenitis suppurativa

1 finding from 1 review

Interventions for hidradenitis suppurativa 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Low

Oral tetracycline vs topical clindamycin

Physician global assessment VAS VAS (0 to 100 mm) · participants with hidradenitis suppurativa

1 finding from 1 review

Interventions for hidradenitis suppurativa 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Low

Topical metronidazole vs oral (oxy)tetracycline

HRQOL ‐ not measured · Participants with rosacea

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Topical metronidazole vs oral (oxy)tetracycline

Participant‐assessed improvement in rosacea severity · Participants with rosacea

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 182 participants
Moderate

Topical metronidazole vs oral (oxy)tetracycline

Proportion of participants with adverse event · Participants with rosacea

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 258 participants
Moderate

Topical metronidazole vs oral (oxy)tetracycline

Physician‐assessed improvement in rosacea severity · Participants with rosacea

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 81 participants
Moderate

Topical metronidazole vs oral (oxy)tetracycline

Assessment of erythema or telangiectasia · Participants with rosacea

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 258 participants
Low

Topical metronidazole vs oral (oxy)tetracycline

Lesion count · Participants with rosacea

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 258 participants
Moderate

Topical metronidazole vs oral (oxy)tetracycline

Time needed until improvement ‐ not measured · Participants with rosacea

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Topical metronidazole vs oral (oxy)tetracycline

Duration of remission ‐ not measured · Participants with rosacea

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for rosacea 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found